Benzimidazole

Benzimidazole

SCHEMBL2950245

O.c1ccc2[nH]cnc2c1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Benzimidazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 known ✓ P09874 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ PDPK1 O15530 1/20 0.48
▸ CA12 O43570 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ TNKS2 Q9H2K2 1/20 0.48
▸ PRKCI P41743 1/20 0.48
▸ KDM4E B2RXH2 6/20 0.47
▸ MAPT P10636 2/20 0.47
▸ RAD52 P43351 1/20 0.47
▸ ALDH1A1 P00352 5/20 0.46
▸ HPGD P15428 3/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ QPCT Q16769 2/20 0.46
▸ QPCTL Q9NXS2 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MMP12 P39900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzimidazole SCHEMBL2971795 1.00 SMN1; SMN2 (0.48) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL1293052 1.00 SMN1; SMN2 (0.48) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL17786061 0.98 KDM4E (0.50) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL29373085 0.98 SMN1; SMN2 (0.47) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL29406970 0.98 SMN1; SMN2 (0.47) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL7773385 0.98 KDM4E (0.50) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL10432218 0.98 KDM4E (0.50) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL4441683 0.98 SMN1; SMN2 (0.47) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL11293000 0.98 KDM4E (0.50) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL31239694 0.98 SMN1; SMN2 (0.47) SMN1; SMN2PDPK1CA12PARP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103193728-A Synthesis process of chiral ionic liquid with (R)-thiazolidinyl-2-thione-4-carboxylic acid as negative ion UNIV XIN JIANG 2013-07-10 — — CN claimed
EP-1421076-A1 HYDRATES OF OPTIONALLY SUBSTITUTED 2-(2-PYRIDINYL)METHYLTHIO-1H-BENZIMIDAZOLES AND METHOD FOR THE PRODUCTION THEREOF Grünenthal GmbH (DE) 2004-05-26 — — EP claimed
WO-2003016301-A1 HYDRATES OF OPTIONALLY SUBSTITUTED 2-(2-PYRIDINYL)METHYLTHIO-1H-BENZIMIDAZOLES AND METHOD FOR THE PRODUCTION THEREOF Grünenthal GmbH (DE) 2003-02-27 — — WO claimed
EP-4644489-A1 WATER-ABSORBING RESIN COMPOSITION, WATER-STOPPING MATERIAL, AND CABLE Sumitomo Seika Chemicals Co., Ltd. (JP) 2025-11-05 — — EP disclosed
WO-2023027236-A1 MICELLE COMPRISING BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT (주)바이오메트릭스 테크놀로지 2023-03-02 — — WO disclosed
CN-108473441-B Poly (phenylene) and m-terphenyl as protecting group for benzimidazolium hydroxide 西蒙弗雷泽大学 2021-12-21 — — CN disclosed
CN-108473441-B Poly (phenylene) and m-terphenyl as protecting group for benzimidazolium hydroxide 西蒙弗雷泽大学 2021-12-21 — — CN disclosed
CN-108473441-B Poly (phenylene) and m-terphenyl as protecting group for benzimidazolium hydroxide 西蒙弗雷泽大学 2021-12-21 — — CN disclosed
US-10800874-B2 Poly(phenylene) and m-Terphenyl as protecting groups for benzimidazolium hydroxides SIMON FRASER UNIVERSITY (CA) 2020-10-13 — — US disclosed
US-10800874-B2 Poly(phenylene) and m-Terphenyl as protecting groups for benzimidazolium hydroxides SIMON FRASER UNIVERSITY (CA) 2020-10-13 — — US disclosed
US-10800874-B2 Poly(phenylene) and m-Terphenyl as protecting groups for benzimidazolium hydroxides SIMON FRASER UNIVERSITY (CA) 2020-10-13 — — US disclosed
WO-2010148314-A2 PREPARATION OF ESOMEPRAZOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS DR. REDDY'S LABORATORIES LTD. (IN) 2010-12-23 — — WO disclosed
US-20100291670-A1 Method for Detecting Candida on Skin KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-11-18 — — US disclosed
US-7763442-B2 Method for detecting candida on skin KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-07-27 — — US disclosed
US-20080057532-A1 Method for detecting Candida on skin KIMBERLY-CLARK WORLDWIDE, INC. 2008-03-06 — — US disclosed
CN-1288176-A Tensile strength and durable fibrous photosensitive base materials EASTMAN KODAK CO (US) 2001-03-21 — — CN disclosed
CN-1284660-A Flexible imaging element using microporous polyester piece EASTMAN KODAK CO (US) 2001-02-21 — — CN disclosed
EP-0091794-B1 PROCESS FOR PREPARING 1.6-DISUBSTITUTED 2-AMINOBENZIMIDAZOLES ELI LILLY AND COMPANY (US) 1988-11-30 — — EP disclosed
US-4434288-A Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles ELI LILLY AND COMPANY (US) 1984-02-28 — — US disclosed
EP-0091794-A1 Process for preparing 1.6-disubstituted 2-aminobenzimidazoles ELI LILLY AND COMPANY (US) 1983-10-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10800874-B2 Poly(phenylene) and m-Terphenyl as protecting groups for benzimidazolium hydroxides H1-4, PNMT, H1-0 PARP1 386/4885SMN1; SMN2 1589/4885PDPK1 1388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback